高级搜索
立即登录 | 免费注册
当前位置 >   首页 > 医药资讯 >  药品动态  > 药品资讯内容

FDA警告,避免孩子和宠物接触喷洒透皮潮热治疗药的上臂

Keep kids and pets away from arms sprayed with transdermal hot-flash product, FDA warns

2010-08-02 【发表评论】
中文 | ENGLISH | 打印| 推荐给好友


ST LOUIS (MD Consult) - On July 29, 2010, the US Food and Drug Administration (FDA) issued a notice regarding a safety concern related to the use of Evamist (estradiol transdermal spray). The FDA has received reports of inadvertent exposure to the product by children and pets.

Evamist was approved by the FDA in July 2007. From that time through June 2010, the FDA has received 8 postmarketing cases of unintended exposure of children to Evamist. The children ranged in age from 3 to 5 years.

Young girls who are exposed to the product may experience signs and symptoms of premature puberty and breast development. Gynecomastia may develop in boys who have been exposed to Evamist. Pets exposed to the product may experience mammary/nipple enlargement and vulvar swelling.

Evamist is a topical product, sprayed on the skin on the inside of the forearm between the elbow and the wrist. It is used by women to reduce hot flashes during menopause.

Children should not be allowed to make contact with the area of the arm where Evamist was sprayed. If contact with children cannot be avoided, it is recommended that a garment with long sleeves be worn to cover the application site. If a child comes in direct contact with the arm where Evamist was sprayed, the child's skin should be washed with soap and water as soon as possible. The child's health care professional should be contacted if signs of exposure become evident.

Pets should not be allowed to lick or touch the arm where Evamist was sprayed. Small pets may be especially sensitive to the estrogen in Evamist. Patients should be advised to contact a veterinarian if a pet exhibits signs of nipple and/or vulvar enlargement or any other signs of illness.

圣路易斯(MD Consult)——2010729日,美国食品药品管理局(FDA)发布了一则与使用Evamist(雌二醇透皮喷剂)有关的安全性通告。FDA已收到有关儿童和宠物意外暴露于此药的报告。

Evamist20077月获得FDA的批准。从那时起直至20106月,FDA已收到8例儿童意外暴露于Evamist的上市后病例,其年龄介于3~5岁。

年幼的女孩暴露于该药品后可出现性早熟和乳房过早发育的症状和体征。男孩暴露于Evamist后会发生男性乳房发育征。宠物暴露于此药后会出现乳房或乳头增大及外阴肿胀。

Evamist是一种局部用药,喷洒在肘腕部之间前臂内侧的皮肤上,用于减少女性更年期潮热。

应避免孩子接触Evamist喷洒区皮肤。若无法避免孩子接触,则建议穿长袖衫覆盖用药区。若孩子直接接触Evamist喷洒区皮肤,则尽快使用肥皂清洗孩子接触区皮肤。若出现暴露相关的体征,则联系医护专业人员进行处置。

应避免宠物舔舐或接触Evamist喷洒区。小型宠物对Evamist中的雌激素尤为敏感。应建议患者在宠物出现乳头和()乳房增大或其他任何患病征象时联系兽医进行处置。


Subjects:
general_primary, endocrinology, diabetes, womans_health
学科代码:
内科学, 内分泌学与糖尿病, 妇产科学

请登录后发表评论, 点击此处登录。

疾病资源中心  疾病资源中心
 病例分析

 王燕燕 王曙

上海交通大学附属瑞金医院内分泌科

患者,女,69岁。2009年1月无明显诱因下出现乏力,当时程度较轻,未予以重视。2009年3月患者乏力症状加重,尿色逐渐加深,大便习惯改变,颜色变淡。4月18日入我院感染科治疗,诉轻度头晕、心慌,体重减轻10kg。无肝区疼痛,无发热,无腹痛、腹泻、腹胀、里急后重,无恶性、呕吐等。入院半月前于外院就诊,查肝功能:ALT 601IU/L,AST 785IU/L,TBIL 97.7umol/L,白蛋白 41g/L,甲状腺功能:游离T3 30.6pmol/L,游离T4 51.9pmol/L,心电图示快速房颤。
 

医学数据库  医学数据库



友情链接:中文版柳叶刀 | MD CONSULT | Journals CONSULT | Procedures CONSULT | eClips CONSULT | Imaging CONSULT | 论文吧 | 世界医学书库 医心网 | 前沿医学资讯网

公司简介 | 用户协议 | 条件与条款 | 隐私权政策 | 网站地图 | 联系我们

 互联网药品信息服务资格证书 | 卫生局审核意见通知书 | 药监局行政许可决定书 
电信与信息服务业务经营许可证 | 京ICP证070259号 | 京ICP备09068478号

Copyright © 2009 Elsevier.  All Rights Reserved.  爱思唯尔版权所有